EWTX logo

Edgewise Therapeutics, Inc. (EWTX) Working Capital

Annual Working Capital:

$451.62M+$141.40M(+45.58%)
December 31, 2024

Summary

  • As of today, EWTX annual working capital is $451.62 million, with the most recent change of +$141.40 million (+45.58%) on December 31, 2024.
  • During the last 3 years, EWTX annual working capital has risen by +$178.37 million (+65.28%).
  • EWTX annual working capital is now at all-time high.

Performance

EWTX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Quarterly Working Capital:

$552.25M-$30.11M(-5.17%)
September 30, 2025

Summary

  • As of today, EWTX quarterly working capital is $552.25 million, with the most recent change of -$30.11 million (-5.17%) on September 30, 2025.
  • Over the past year, EWTX quarterly working capital has increased by +$71.78 million (+14.94%).
  • EWTX quarterly working capital is now -5.17% below its all-time high of $582.36 million, reached on June 30, 2025.

Performance

EWTX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXbalance sheet metrics

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

EWTX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+45.6%+14.9%
3Y3 Years+65.3%+54.8%
5Y5 Years+1871.2%+340.7%

EWTX Working Capital Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+65.3%-5.2%+96.1%
5Y5-Yearat high+1871.2%-5.2%+340.7%
All-TimeAll-Timeat high+1871.2%-5.2%+340.7%

EWTX Working Capital History

DateAnnualQuarterly
Sep 2025
-
$552.25M(-5.2%)
Jun 2025
-
$582.36M(+38.0%)
Mar 2025
-
$422.06M(-6.5%)
Dec 2024
$451.62M(+45.6%)
$451.62M(-6.0%)
Sep 2024
-
$480.48M(-4.3%)
Jun 2024
-
$502.26M(-4.7%)
Mar 2024
-
$526.83M(+69.8%)
Dec 2023
$310.23M
$310.23M(+10.2%)
Sep 2023
-
$281.58M(-6.9%)
Jun 2023
-
$302.60M(-5.6%)
DateAnnualQuarterly
Mar 2023
-
$320.65M(-5.8%)
Dec 2022
$340.41M(+24.6%)
$340.41M(-4.6%)
Sep 2022
-
$356.84M(+46.2%)
Jun 2022
-
$244.13M(-5.6%)
Mar 2022
-
$258.61M(-5.4%)
Dec 2021
$273.25M(+118.1%)
$273.25M(-3.9%)
Sep 2021
-
$284.49M(-4.0%)
Jun 2021
-
$296.23M(-3.1%)
Mar 2021
-
$305.69M(+144.0%)
Dec 2020
$125.30M(+446.9%)
$125.30M
Dec 2019
$22.91M
-

FAQ

  • What is Edgewise Therapeutics, Inc. annual working capital?
  • What is the all-time high annual working capital for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. annual working capital year-on-year change?
  • What is Edgewise Therapeutics, Inc. quarterly working capital?
  • What is the all-time high quarterly working capital for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. quarterly working capital year-on-year change?

What is Edgewise Therapeutics, Inc. annual working capital?

The current annual working capital of EWTX is $451.62M

What is the all-time high annual working capital for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high annual working capital is $451.62M

What is Edgewise Therapeutics, Inc. annual working capital year-on-year change?

Over the past year, EWTX annual working capital has changed by +$141.40M (+45.58%)

What is Edgewise Therapeutics, Inc. quarterly working capital?

The current quarterly working capital of EWTX is $552.25M

What is the all-time high quarterly working capital for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high quarterly working capital is $582.36M

What is Edgewise Therapeutics, Inc. quarterly working capital year-on-year change?

Over the past year, EWTX quarterly working capital has changed by +$71.78M (+14.94%)
On this page